CT
Cirrus Therapeutics, Inc.
SEC filingOther Technology · Cambridge, MA
Amount raised$6.7Msold at filing
Total offering$15.7M$9M still open
Investors in the raise8count reported to the SEC
FiledAug 19, 2025first sale Aug 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Alexandra CantleyDirector
Andrew DickDirector, Promoter
Khoo ShihDirector
Ying Kai ChanExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.